Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obeticholic acid
obeticholic acid
Pharma turn to NASH unlikely to mirror meteoric rise of hep C
Biopharma Dive
Mon, 05/21/18 - 06:25 pm
NASH
Intercept Pharma
obeticholic acid
Intercept Presents Data form Ph III Substudy That Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients
CP Wire
Fri, 04/13/18 - 01:10 pm
INTERCEPT
primary biliary cholangitis
obeticholic acid
OCA
Intercept Presents Data form Ph III Substudy That Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients
Fri, 04/13/18 - 12:53 pm
INTERCEPT
primary biliary cholangitis
obeticholic acid
Intercept cuts targets for pivotal NASH study
BioPharma Dive
Tue, 02/14/17 - 09:37 am
Intercept Pharma
NASH
clinical trials
OCA
obeticholic acid
Intercept Wins FDA Approval for Drug to Treat Liver Disease
Bloomberg
Mon, 05/30/16 - 10:08 am
Intercept Pharma
FDA
Ocaliva
obeticholic acid
primary biliary cirrhosis
Looking ahead at orphan drugs' future: More breakthroughs, exploding sales
BioPharma Dive
Wed, 02/17/16 - 09:49 pm
orphan drugs
Sumitomo Dainippon
obeticholic acid
AbbVie
venetoclax
Actelion
Uptravi
Seven $1 billion-plus drugs seen reaching market in 2016
Yahoo/Reuters
Thu, 02/4/16 - 09:29 am
Intercept Pharmaceuticals
Gilead Sciences
Roche
AbbVie
Merck
obeticholic acid
emtricitabine
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
Yahoo
Mon, 08/31/15 - 08:26 am
FDA
Intercept Pharma
obeticholic acid
priority review
primary biliary cirrhosis
5 Biotech Stocks On Deck With The FDA
Yahoo/Benzinga
Tue, 06/30/15 - 06:13 pm
FDA
Alnylam
Patisiran
Esperion Therapeutics
ETC-1002
Intercept Pharmaceuticals
obeticholic acid
Sarepta Therapeutics
eteplirsen
Tekmira
TKM-PLK1
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
24/7 Wall St
Mon, 03/16/15 - 09:16 am
Amgen
evolocumab
Biogen Idec
BIIB037
OCA
obeticholic acid
Intercept Pharmaceuticals
Intercept Pharma, Government Scientists Spar Over Negative Safety of Liver Drug, Emails Show
TheStreet.com
Tue, 05/20/14 - 09:10 am
Intercept Pharma
liver disease
OCA
obeticholic acid
8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Tue, 04/8/14 - 09:46 am
Zohydro
Zogenix
Zybrestat
Oxigene
Arikayce
Insmed
obeticholic acid
Intercept Pharmaceuticals
Intercept Announces Positive Pivotal Phase 3 POISE Trial Results
Yahoo/Globe Newswire
Sun, 03/16/14 - 11:46 am
Intercept Pharma
obeticholic acid
primary biliary cirrhosis
Intercept Liver Drug Is A Game Changer For The Biotech Industry
Seeking Alpha
Sun, 01/12/14 - 09:47 am
nonalcoholic steatohepatitis
Intercept Pharma
obeticholic acid
Intercept stock triples on liver disease study
Yahoo/AP
Fri, 01/10/14 - 08:20 am
Intercept Pharma
liver disease
obeticholic acid
Pages
« first
‹ previous
1
2